切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2023, Vol. 17 ›› Issue (06) : 711 -719. doi: 10.3877/cma.j.issn.1674-0785.2023.06.015

临床研究

北京市石景山区40岁及以上居民慢性阻塞性肺疾病患病情况及相关危险因素分析
孙培培, 张二明, 时延伟, 赵春燕, 宋萍萍, 张硕, 张克, 周玉娇, 赵璨, 闫维, 吴蓉菊, 宋丽萍, 郭伟安, 马石头, 安欣华, 包曹歆, 向平超()   
  1. 100144 北京,北京大学首钢医院呼吸与危重症医学科
    100043 北京,石景山区疾病预防控制中心
  • 收稿日期:2022-05-12 出版日期:2023-06-15
  • 通信作者: 向平超

Prevalence and risk factors of chronic obstructive pulmonary disease in residents aged 40 years and above in Shijingshan district of Beijing

Peipei Sun, Erming Zhang, Yanwei Shi, Chunyan Zhao, Pingping Song, Shuo Zhang, Ke Zhang, Yujiao Zhou, Can Zhao, Wei Yan, Rongju Wu, Liping Song, Weian Guo, Shitou Ma, Xinhua An, Caoxin Bao, Pingchao Xiang()   

  1. Blood Purification Center, the First Affiliated Hospital of Wannan Medical College, Wuhu 241000, China
    Shijingshan District Center for Disease Control and Prevention, Beijing 100043, China
  • Received:2022-05-12 Published:2023-06-15
  • Corresponding author: Pingchao Xiang
引用本文:

孙培培, 张二明, 时延伟, 赵春燕, 宋萍萍, 张硕, 张克, 周玉娇, 赵璨, 闫维, 吴蓉菊, 宋丽萍, 郭伟安, 马石头, 安欣华, 包曹歆, 向平超. 北京市石景山区40岁及以上居民慢性阻塞性肺疾病患病情况及相关危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2023, 17(06): 711-719.

Peipei Sun, Erming Zhang, Yanwei Shi, Chunyan Zhao, Pingping Song, Shuo Zhang, Ke Zhang, Yujiao Zhou, Can Zhao, Wei Yan, Rongju Wu, Liping Song, Weian Guo, Shitou Ma, Xinhua An, Caoxin Bao, Pingchao Xiang. Prevalence and risk factors of chronic obstructive pulmonary disease in residents aged 40 years and above in Shijingshan district of Beijing[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(06): 711-719.

目的

研究北京石景山区40岁及以上居民慢性阻塞性肺疾病(COPD)的患病情况及相关危险因素。

方法

2019年6月至12月采用随机抽样方法对北京石景山区10个社区40岁及以上居民进行监测。对研究对象进行问卷调查和身体测量,所有研究对象均进行吸入支气管舒张药物前、后肺功能检查以调查COPD患病情况及相关危险因素。

结果

共有4096名监测对象具有可靠的药后肺功能结果并被纳入最终研究,其中男性1886名(46.0%),女性2210名(54.0%)。总体患病率为10.2%,男性为13.8%,高于女性的7.1%,并且随着年龄的增加COPD患病率亦升高。在诊断的COPD患者中,49.8%的患者为中-重度阻塞(GOLD分级Ⅱ~Ⅳ级),37.5%的人群做过肺功能检查,12.5%了解自己曾诊断COPD。吸烟是COPD的主要危险因素(OR=1.94,95%CI:1.45~2.58,P<0.05),COPD的患病率与吸烟包年数呈正相关,仍有已知自己为COPD的患者未戒烟。其他的危险因素包括男性(OR=1.52,95%CI:1.22~2.05,P<0.05)、年龄增加(OR=1.66,95%CI:1.34~2.41,P<0.05)、呼吸道疾病家族史(OR=1.73,95%CI:1.33~2.23,P<0.05),幼时支气管炎/肺炎病史(OR=2.035,95%CI:1.339~3.095,P<0.05)。

结论

北京石景山区40岁及以上居民COPD患病率较高。目前需要制定针对疾病预防、早期诊断、疾病管理的策略以降低COPD疾病负担。

Objective

To investigate the prevalence and risk factors of chronic obstructive pulmonary disease (COPD) in residents aged 40 years and above in Shijingshan district of Beijing.

Methods

The residents aged 40 years and above in 10 communities of Shijingshan district of Beijing were included by random sampling method from June to December 2019. Questionnaire survery, physical measurement, pulmonary function examination before and after bronchodilator treatment were conducted on all the subjects. COPD was diagnosed based on the 2020 Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria. The prevalence of COPD and related risk factors were investigated in those subjects.

Results

A total of 4 096 participants had reliable post-bronchodilator results and were included in the final analysis, including 1 886 males (46.0%) and 2 210 females (54.0%). The overall prevalence of COPD was 10.2%, and it was higher in men (13.8%) than in women (7.1%). The prevalence of COPD increased with age. Among adults with COPD, 49.8% (95%) had moderate or severe disease (GOLD stageⅡ-Ⅳ), 37.5% reported that they had a previous pulmonary function test, and 12.5% knew their diagnosis of COPD. Smoking was the main risk factor for COPD (odds ratio [OR]=1.94,95% confidence interval [CI]:1.45-2.58, P<0.05). The prevalence of COPD was positively related to the pack-years of smoking. Certain COPD patients had not quit smoking although they knew that they had COPD. Other risk factors for COPD included male gender (OR=1.52, 95%CI: 1.22-2.05, P<0.05), older age (OR=1.66, 95%CI: 1.34-2.41, P<0.05), family history of lung disease (OR=1.73, 95%CI: 1.33-2.23, P<0.05), and history of bronchitis/pneumonia in childhood (OR=2.035, 95%CI: 1.339-3.095, P<0.05).

Conclusions

The prevalence of COPD in Shijingshan residents aged 40 and above is high. Strategies for prevention, early diagnosis, and management of COPD are urgently needed to reduce COPD-related burden.

表1 本研究抽样方法
表1 本研究人群特征分析
项目 总体(n=4096) 男性(n=1886) 女性(n=2210)
平均年龄(岁,
x¯
60.70±11.44 60.35±11.53 60.99±11.34
体质指数(kg/m2
x¯
±s
25.37±5.60 25.65±7.08 25.14±3.86
教育水平(%)
小学及更低 8.6 5.7 11.1
中学 65.5 64.2 66.6
大学及更高 25.9 30.1 22.3
吸烟(%)
从不吸烟 65.3 32.3 93.5
以前吸烟 11.8 23.3 1.9
目前仍吸烟 22.9 44.4 4.6
吸烟暴露(平均包年数) 23.23 24.07 18.38
0包(%) 65.3 32.3 93.5
1~9包(%) 8.4 14.3 3.4
10~19包(%) 7.9 15.4 1.5
≥20包(%) 18.4 38.0 1.6
家庭被动吸烟(%)
0 66.4 81.2 53.8
被动1 27.8 14.9 38.8
被动≥2 5.8 3.9 7.4
工作被动吸烟(%)
0 55.0 46.0 62.6
被动1 4.2 4.4 3.9
被动≥2 40.9 46.9 33.5
接触油烟(%) 86.1 78.5 92.6
接触煤燃料(%) 13.8 14.2 13.5
粉尘接触(%) 26.6 32.5 21.5
工作性质(%)
无业 5.0 3.6 6.3
务农 2.9 1.9 3.7
技术 37.1 43.8 31.4
管理 19.6 23.1 16.6
服务 17.1 12.0 21.5
其他 18.3 15.7 20.6
收入(%)
低等 4.2 3.0 5.2
中等 64.9 55.9 72.7
高等 30.9 41.1 22.2
早产儿(%) 0.8 0.6 1.0
过敏史(%) 19.7 17.3 21.8
家族史(%) 15.6 14.4 16.6
肺结核病史(%) 3.5 3.9 3.1
幼时支气管炎/肺炎病史(%) 8.7 8.3 9.0
幼时慢性咳嗽(%) 5.3 4.1 6.4
听过COPD(%) 37.1 32.2 41.2
未听过COPD(%) 62.9 67.7 58.8
做过肺功能(%) 24.0 23.5 24.3
未做过肺功能(%) 76.0 76.5 75.7
咳嗽(%)
从不 55.9 52.9 58.4
偶尔 39.5 41.4 37.8
经常 4.6 5.7 3.8
咳痰(%)
从不 60.7 57.5 63.4
偶尔 35.5 37.9 33.6
经常 3.8 4.7 3.0
喘息(%)
从不 77.1 75.2 78.6
偶尔 20.6 22.1 19.4
经常 2.3 2.7 2.0
气短(%)
从不 59.8 58.0 61.3
偶尔 36.0 37.5 34.7
经常 4.2 4.5 4.0
疲劳(%)
从不 56.6 54.5 58.5
偶尔 37.0 39.0 35.3
经常 6.4 6.6 6.2
肺功能(
x¯
±s
药前FEV1(L) 2.47±2.87 2.87±4.14 2.12±0.49
药后FEV1(L) 2.57±4.19 3.01±6.11 2.19±0.49
药前FVC(L) 3.04±0.95 3.51±1.07 2.63±0.58
药后FVC(L) 3.23±6.21 3.54±0.76 2.95±8.44
药前FEV1/FVC(%) 82.06±12.31 79.07±8.55 84.65±16.8
药后FEV1/FVC(%) 81.33±13.80 80.02±8.41 82.46±17.06
表2 不同调查人群慢性阻塞性肺疾病(COPD)患病率情况(%)
项目 总体 男性 女性 项目 总体 男性 女性
患病率 10.2 13.8 7.1 患病率 10.2 13.8 7.1
年龄(岁) 防护
40~49 5.6 6.8 4.5 13.3 13.4 13.1
50~59 9.6 11.1 8.1 15.7 19.5 11.1
60~69 9.7 15.7 6.5 χ2 1.255 4.041 0.480
70~79 11.2 18.3 6.5 P 0.263 0.044 0.488
80以上 19.5 27.2 12.6 早产儿
χ2 51.676 48.251 13.786 8.8 8.3 9.1
P <0.001 <0.001 <0.001 10.2 13.8 7.0
体质指数(kg/m2 χ2 0.067 0.302 0.140
<18.5 8.6 15.8 7.7 P 0.796 0.583 0.708
≥18.5~24 12.4 16.9 8.4 过敏史
≥24~28 9.4 12.9 6.3 12.0 15.0 10.0
≥28 8.1 10.6 5.9 9.7 13.5 6.2
χ2 12.481 8.449 2.853 χ2 3.825 0.514 7.992
P 0.006 0.038 0.415 P 0.050 0.473 0.005
教育水平 呼吸道家族史
小学或更低 13.9 25.0 9.0 16.1 22.4 11.5
中学 10.4 14.5 7.0 9.1 12.3 6.2
大学或更高 8.3 10.0 6.3 χ2 29.696 19.966 13.042
χ2 9.578 18.738 1.833 P <0.001 <0.001 <0.001
P 0.008 <0.001 0.400 肺结核病史
收入水平 18.3 23.0 13.2
7.0 8.8 6.1 9.9 13.4 6.9
10.8 15.9 7.4 χ2 10.717 5.470 4.080
9.3 11.2 6.1 P 0.001 0.019 0.043
χ2 0.196 9.444 1.122 幼时肺炎支气管炎
P 0.123 0.009 0.571 20.2 28.7 13.5
工作性质 9.2 12.4 6.4
无业 10.7 14.9 8.6 χ2 42.921 31.889 13.906
务农 12.0 19.4 8.6 P <0.001 <0.001 <0.001
技术 11.3 14.3 7.8 幼时慢性咳嗽病史
管理 9.5 13.6 4.6 26.0 41.6 17.6
服务 8.4 13.7 5.9 9.3 12.1 6.5
其他 9.7 11.8 8.4 χ2 63.871 52.098 24.634
χ2 5.595 2.194 7.269 P <0.001 <0.001 <0.001
P 0.348 0.822 0.201 咳嗽
吸烟状态 从不 7.5 9.2 6.2
从不吸烟 7.2 7.9 7.0 偶尔 12.6 17.7 7.8
吸烟 15.8 16.6 8.3 经常 21.6 28.0 13.3
以前吸烟 19.5 20.5 9.3 χ2 54.869 45.714 6.970
仍吸烟 13.8 14.6 7.9 P <0.001 <0.001 0.031
χ2 74.975 26.379 0.381 咳痰
P <0.001 <0.001 0.537 从不 7.6 9.2 6.4
吸烟暴露(包年) 偶尔 13.3 18.5 8.2
0 7.2 7.9 7.0 经常 21.9 31.8 9.0
<9 12.7 14.1 7.9 χ2 56.613 56.326 2.960
<19 14.9 15.5 9.1 P <0.001 <0.001 0.228
患病率 10.2 13.8 7.1 患病率 10.2 13.8 7.1
>20 17.6 18.0 8.6 喘息
χ2 4.431 2.493 0.047 从不 6.9 9.2 5.0
P 0.109 0.288 0.977 偶尔 19.2 25.7 12.9
室内油烟暴露 经常 38.9 46.0 31.1
9.3 13.8 6.1 χ2 198.789 118.654 72.693
15.3 13.8 18.9 P <0.001 <0.001 <0.001
χ2 13.321 <0.001 37.876 气短
P <0.001 0.996 <0.001 从不 6.5 9.3 4.3
燃煤暴露 偶尔 14.0 18.2 10.2
10.6 15.7 6 经常 28.2 34.1 22.5
9.3 13.5 7.2 χ2 121.387 59.519 59.566
χ2 0.327 0.935 0.569 P <0.001 <0.001 <0.001
P 0.567 0.334 0.451 疲劳
工作中接触粉尘 从不 8.4 12.3 5.3
14.6 16.6 12.0 偶尔 12.1 15.5 8.8
8.5 12.4 5.7 经常 14.9 16.1 13.9
χ2 32.264 6.223 22.517 χ2 20.877 4.400 19.866
P <0.001 0.013 <0.001 P <0.001 0.111 <0.001
表3 本调查慢性阻塞性肺疾病(COPD)患者GOLD分级[例(%)]
表4 本调查慢性阻塞性肺疾病(COPD)患者的症状分布(%)
表5 不同人群对慢性阻塞性肺疾病(COPD)的认知情况(%)
表6 不同GOLD分级患者对慢性阻塞性肺疾病(COPD)的认知情况(%)
1
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2020 report) [EB/OL].

URL    
2
World Health Organization. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach [EB/OL]. Geneva: WHO; 2018.
3
GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016 [J]. Lancet, 2017, 390(10100): 1151-1210.
4
Xu G, Zhang Z, Lv Q, et al. NSFC health research funding and burden of disease in China [J]. PLoS One, 2014, 9(11): e111458.
5
Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis [J]. J Glob Health, 2015, 5(2): 020415.
6
Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey [J]. Am J Respir Crit Care Med, 2007, 176(8): 753-760.
7
Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study [J]. Lancet, 2018, 391(10131): 1706-1717.
8
Fang L, Gao P, Bao H, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study [J]. Lancet Respir Med, 2018, 6(6): 421-430.
9
沈宁, 姚婉贞, 朱红. 北京市延庆县慢性阻塞性肺疾病患者的认知情况调查 [J]. 中华结核和呼吸杂志, 2008, 31(3): 121-125
10
陈乾华, 窦志芳, 潘娜, 等. 北京朝阳区慢性阻塞性肺疾病的流行病学调查 [J]. 中国热带医学, 2010, 10(9): 1086-1094.
11
Zhu B, Wang Y, Ming J, et al. Disease burden of COPD in China: a systematic review [J]. Int J Chron Obstruct Pulmon Dis, 2018, 13: 1353-1364.
12
Pleasants RA, Riley IL, Mannino DM. Defining and targeting health disparities in chronic obstructive pulmonary disease [J]. Int J Chron Obstruct Pulmon Dis, 2016, 11: 2475-2496.
13
Rabe KF, Watz H. Chronic obstructive pulmonary disease [J]. Lancet, 2017, 389(10082): 1931-1940.
14
兰丰铃, 王胜锋, 曹卫华, 等. 慢性阻塞性肺疾病危险因素流行病学研究新进展 [J]. 中华疾病控制杂志, 2014, 18(10): 998-1002.
15
Menezes AM, Perez-Padilla R, Jardim JR, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study [J]. Lancet, 2005, 366(9500): 1875-1881.
16
Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study [J]. Lancet, 2007, 370(9589): 741-750.
17
Rigden HM, Alias A, Havelock T, et al. Squamous metaplasia is increased in the bronchial epithelium of smokers with chronic obstructive pulmonary disease [J]. PLoS One, 2016, 11(5): e0156009.
18
Yaghi A, Zaman A, Cox G, et al. Ciliary beating is depressed in nasal cilia from chronic obstructive pulmonary disease subjects [J]. Respir Med, 2012, 106(8): 1139-1147.
19
Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease [J]. N Engl J Med, 2004, 350(26): 2645-2653.
20
Jayes L, Haslam PL, Gratziou CG, et al. SmokeHaz: Systematic Reviews and Meta-analyses of the Effects of Smoking on Respiratory Health [J]. Chest, 2016, 150(1): 164-179.
21
Kohansal R, Martinez-Camblor P, Agustí A, et al. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort [J]. Am J Respir Crit Care Med, 2009, 180(1): 3-10.
22
van Eerd EA, van der Meer RM, van Schayck OC, et al. Smoking cessation for people with chronic obstructive pulmonary disease [J]. Cochrane Database Syst Rev, 2016, 2016(8): CD010744.
23
Hersh CP, DeMeo DL, Al-Ansari E, et al. Predictors of survival in severe, early onset COPD [J]. Chest, 2004, 126(5): 1443-1451.
24
中华人民共和国国家卫生和计划生育委员会. 中国临床戒烟指南(2015年版) [J]. 中华健康管理学杂志, 2016, 10(2): 88-95.
25
Yin P, Jiang CQ, Cheng KK, et al. Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study [J]. Lancet, 2007, 370(9589): 751-757.
26
Hagstad S, Bjerg A, Ekerljung L, et al. Passive smoking exposure is associated with increased risk of COPD in never smokers [J]. Chest, 2014, 145(6): 1298-1304.
27
Pleasants RA, Riley IL, Mannino DM. Defining and targeting health disparities in chronic obstructive pulmonary disease [J]. Int J Chron Obstruct Pulmon Dis, 2016, 11: 2475-2496.
28
Grigsby M, Siddharthan T, Chowdhury MA, et al. Socioeconomic status and COPD among low- and middle-income countries [J]. Int J Chron Obstruct Pulmon Dis, 2016, 11: 2497-2507.
29
van Gemert F, Chavannes N, Kirenga B, et al. Socio-economic factors, gender and smoking as determinants of COPD in a low-income country of sub-Saharan Africa: FRESH AIR Uganda [J]. NPJ Prim Care Respir Med, 2016, 26: 16050.
30
Yin P, Zhang M, Li Y, et al. Prevalence of COPD and its association with socioeconomic status in China: findings from China Chronic Disease Risk Factor Surveillance 2007 [J]. BMC Public Health, 2011, 11: 586.
31
Melville AM, Pless-Mulloli T, Afolabi OA, et al. COPD prevalence and its association with occupational exposures in a general population [J]. Eur Respir J, 2010, 36(3): 488-493.
32
Caillaud D, Lemoigne F, Carré P, et al. Association between occupational exposure and the clinical characteristics of COPD [J]. BMC Public Health, 2012, 12: 302.
33
Tual S, Clin B, Levêque-Morlais N, et al. Agricultural exposures and chronic bronchitis: findings from the AGRICAN (AGRIculture and CANcer) cohort [J]. Ann Epidemiol, 2013, 23(9): 539-545.
34
Lou P, Zhu Y, Chen P, et al. Vulnerability of patients with chronic obstructive pulmonary disease according to gender in China [J]. Int J Chron Obstruct Pulmon Dis, 2012, 7: 825-832.
[1] 明昊, 肖迎聪, 巨艳, 宋宏萍. 乳腺癌风险预测模型的研究现状[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 287-291.
[2] 庄燕, 戴林峰, 张海东, 陈秋华, 聂清芳. 脓毒症患者早期生存影响因素及Cox 风险预测模型构建[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 372-378.
[3] 黄鸿初, 黄美容, 温丽红. 血液系统恶性肿瘤患者化疗后粒细胞缺乏感染的危险因素和风险预测模型[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 285-292.
[4] 罗文斌, 韩玮. 胰腺癌患者首次化疗后中重度骨髓抑制的相关危险因素分析及预测模型构建[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 357-362.
[5] 贺斌, 马晋峰. 胃癌脾门淋巴结转移危险因素[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 694-699.
[6] 林凯, 潘勇, 赵高平, 杨春. 造口还纳术后切口疝的危险因素分析与预防策略[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 634-638.
[7] 杨闯, 马雪. 腹壁疝术后感染的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 693-696.
[8] 周艳, 李盈, 周小兵, 程发辉, 何恒正. 不同类型补片联合Nissen 胃底折叠术修补食管裂孔疝的疗效及复发潜在危险因素[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 528-533.
[9] 张伟伟, 陈启, 翁和语, 黄亮. 随机森林模型预测T1 期结直肠癌淋巴结转移的初步研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 389-393.
[10] 贾玲玲, 滕飞, 常键, 黄福, 刘剑萍. 心肺康复在各种疾病中应用的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 859-862.
[11] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
[12] 闫维, 张二明, 张克, 安欣华, 向平超. 北京市石景山区40岁及以上居民早期慢性阻塞性肺疾病异质性及影响因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 533-540.
[13] 李文哲, 王毅, 崔建, 郑启航, 王靖彦, 于湘友. 新疆维吾尔自治区重症患者急性肾功能异常的危险因素分析[J/OL]. 中华卫生应急电子杂志, 2024, 10(05): 269-276.
[14] 刘志超, 胡风云, 温春丽. 山西省脑卒中危险因素与地域的相关性分析[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 424-433.
[15] 曹亚丽, 高雨萌, 张英谦, 李博, 杜军保, 金红芳. 儿童坐位不耐受的临床进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 510-515.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?